Abstract
BACKGROUND Peripheral inflammation is often associated with depressive disorders, and immunological biomarkers of depression remain a focus of investigation.
METHODS We performed RNA-seq analysis of RNA transcripts of human peripheral blood mononuclear cells from a case-control study including subjects with self-reported depression in the pre-symptomatic state of major depressive disorder and analyzed differentially expressed genes (DEGs) and the frequency of intron retention (IR) using rMATS.
RESULTS Among the statistically significant DEGs identified, 651 upregulated and 820 downregulated genes were enriched in the Gene Ontology term ‘innate and adaptive immunity’. The upregulated DEGs were particularly enriched in the term ‘bacterial infection and phagocytosis’, whereas the downregulated DEGs were enriched in the terms ‘antigen presentation’ and ‘T-cell proliferation and maturation’. We also analyzed 158 genes for which IR was increased (IncIR) and 211 genes for which IR was decreased (DecIR) among the depressed subjects. The Gene Ontology terms associated with IncIR and DecIR were very similar to those of the up- and downregulated genes, respectively, with a preponderance of the term ‘ciliary assembly and function’ for DecIR. Moreover, the results of the network analysis also showed that a Japanese herbal medicine could partially mitigate the severity of depression among depressed patients. Inclusion of both IncIR and DecIR genes in the network analysis revealed several pathways related to the ability of patients to recover from depression.
CONCLUSION Depression was found to be associated with activation of the innate immune response and relative inactivation of T-cell signaling. The DEGs we identified reflect physiological demands that are controlled at the transcriptional level, whereas the IR results reflect a more direct mechanism for monitoring protein homeostasis. Accordingly, an overall increase in IR is a stress response, and intron-retained transcripts are sensors of the physiological state of the cytoplasm. In particular, detection of increased IR in cilia-specific genes apparently correlates with defects in ciliary function or immunological synapse in depressed subjects. The results demonstrate the potential of relative IR as a biomarker for the immunological stratification of depressed patients and the utility of IR for the discovery of novel pathways involved in recovery from depression.
Competing Interest Statement
N.O., K.O. and A.M. received a research grant from TSUMURA and CO. Although TSUMURA is a manufacturer of the Japanese herbal (Kampo) medicine, the company did not provide the Kampo used in this study, which was prepared at the Kitasato University Oriental Medicine Research Center. All research members of this study declare no potential conflicts of interest.
Clinical Trial
UMIN000045707; https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000052165
Funding Statement
N.O., K.O. and A.M. received a research grant from TSUMURA and CO. Although TSUMURA is a manufacturer of the Japanese herbal (Kampo) medicine, the company did not provide the Kampo used in this study, which was prepared at the Kitasato University Oriental Medicine Research Center. All research members of this study declare no potential conflicts of interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research has been reviewed by the Kitasato Institute Hospital, Research Ethics Committee, approved and assigned research number 21037. The experiment was registered in UMIN-ID：UMIN000045707 URL：https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000052165. Please note that the Kitasato Institute Hospital, Research Ethics Committee in Japan deliberates in accordance with the Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Several sentences in Discussion were revised for readers to understand correctly the copntent.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
